Company intelligence / Profile preview

Beike Biotechnology

Shenzhen, Guangdong, Chinabeikebiotech.com ↗

Ownership: Private
Employees: ~300
Development stage: Commercial

Overview

Beike has provided partner hospitals with stem cells for the treatment of over 33,500 patients since its founding. The company operates more than nine GMP-standard research/cell processing laboratories across China. It was the first adult stem cell processing laboratory accredited by CNAS in China and the first Chinese cord blood bank accredited by AABB. Clinical results have shown improvements in various chronic neurological and autoimmune conditions as reported by patient families; however, peer-reviewed large-scale trial data are limited or unpublished publicly[1][3][10].

Therapeutic areas: OtherCardiovascularImmunologyNeurology
Modalities: Adult stem cells (including umbilical cord blood, umbilical cord tissue, bone marrow-derived stem cells)Immunotherapy treatments[10][1][4]
Industry: Biotech

Drug pipeline

13 assets

human umbilical cord mesenchymal stem cells

12 more assets in the full pipeline.

Partnerships

Shixin Hospital partnership established in China (2023)[6]Collaborations with over thirty hospitals across Asia[9]Founding investment from Peking University & Hong Kong University of Science & Technology[10]

Beyond the preview

Go deeper on Beike Biotechnology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Beike Biotechnology.